Navigation Links
InfuSystem Pays Down Term Loan by $6.1 Million Year-to-Date
Date:4/8/2009

MADISON HEIGHTS, Mich., April 8 /PRNewswire-FirstCall/ -- InfuSystem (OTC Bulletin Board: INHI; INHIW; INHIU), the leading provider of ambulatory infusion pumps and associated clinical services, today announced that it has made a $5.3 million payment on its Term Loan in addition to its normal quarterly $818,000 payment. As a result of the combined payments year-to-date, InfuSystem has reduced the total amount outstanding on its Term Loan by $6.1 million, to $24.1 million. The Term Loan was a result of the sale of InfuSystem, Inc. from its former parent company, completed in October 2007.

Mr. Steve Watkins, Chief Executive Officer, commented, "InfuSystem continues to generate strong free cash flow, which has enabled us to rapidly pay down our Term Loan. The Term Loan originally stood at $32.7 million as of October 2007, and in less than 18 months, we have reduced the principal amount due by over $8.5 million. We plan to continue aggressively paying down this loan, while maintaining a solid cash position on our balance sheet."

About InfuSystem Holdings, Inc.

InfuSystem is the leading provider of ambulatory infusion pumps and associated clinical services for oncology practices and their patients in the U.S. These pumps allow for the gradual delivery of a drug over a period of days in the privacy of one's home, compared to bolus infusion chemotherapy treatments that are given in a single high dose over a short period of time. Improved efficacy of the drugs, patient comfort, reimbursement to doctors for appropriate services and continuity of care all play a role in the growing trend toward this form of treatment. InfuSystem's pumps are primarily used for colorectal cancer, but they have been approved for other forms of cancer, thereby greatly enhancing the market opportunity for InfuSystem.

Forward-Looking Statements

Except for the historical information cont
'/>"/>

SOURCE InfuSystem Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. InfuSystem Holdings Reports 12.9% Revenue Increase and $3.3 Million of Adjusted EBITDA for the Fourth Quarter of 2008
2. InfuSystem Holdings Provides Business Update and Comments on First Quarter 2008 Financial Results
3. InfuSystem Holdings Appoints Two New Board Members
4. ORTHOCON Announces Appointment of New CEO and $25 Million Series B Financing
5. Small-Cell Lung Cancer Drug Market Will More Than Double to Over $684 Million in 2017
6. Misonix Announces the Sale of Its Ultrasonic Laboratory Business for $3.5 Million to iSonix LLC
7. Susan G. Komen For The Cure(R) to Invest $60 Million in Research to Accelerate Breast Cancer Cures, Eliminate Disparities, Improve Diagnoses
8. The Healy Law Firm Represents Plaintiff in $12 Million Settlement with Clark USA Over Fatal Illinois Oil Refinery Accident
9. Siemens Financial Services, Inc. Provides $29.5 Million Credit Package to Avanti Health System
10. Partnership for Prescription Assistance Celebrates Four-Year Anniversary; Helps More Than 5.7 Million Uninsured Patients Across United States
11. Harris Corporation Awarded $14 Million Contract to Develop Multi-Hospital Military Health System Network with Image-Sharing Capabilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ... 2015 , ... North American Seminars will present seventeen ... . These seventeen courses are pre-approved for CME credit for Physical therapists, ... the Older Adult , August 22, 2015 - August 23, 2015 presented ...
(Date:7/28/2015)... Orange, NJ (PRWEB) , ... July 28, 2015 , ... ... on the sidelines – or in your easy chair? Luckily, there are plenty of ... Kadimcherla, MD , an orthopedic spine surgeon at Atlantic Spine Center . ...
(Date:7/28/2015)... ... ... President of the Veterans Fund of the United States, managing the United Veteran Beacon House ... a campaign to help homeless Veterans by giving them “A hand up – not a ... the UVBH assists and supports Vets through the Veterans Fund of the United States ...
(Date:7/27/2015)... ... ... Dr. Robert G. Schwartz , principal of Greenville, SC-based Piedmont Physical Medicine ... in order to offer his patients a new system of care utilizing laser therapy ... Peripheral neuropathy is a disease caused by damage to the peripheral nerves, and typically ...
(Date:7/27/2015)... ... July 28, 2015 , ... Combination Product GMP Compliance:, Understanding FDA’s ... EDT, http:// http://www.fdanews.com/comboproductgmpcompliance , Manufacturing a drug or device is ... things can get messy in a hurry. In a 46-page draft guidance released in ...
Breaking Medicine News(10 mins):Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 2Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 3Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 4Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 5Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 6Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 7Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 8Health News:Safe Cardio for Back Pain Sufferers 2Health News:Safe Cardio for Back Pain Sufferers 3Health News:Veterans Fund of the United States Launches “Adopt A Homeless Veteran” Campaign 2Health News:Veterans Fund of the United States Launches “Adopt A Homeless Veteran” Campaign 3Health News:Piedmont Physical Medicine & Rehabilitation, P.A. Partners with Realief® Neuropathy Centers to Offer Peripheral Neuropathy Laser Treatment 2Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 2Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 3Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 4
... progression, mouse study suggests , , MONDAY, April 14 (HealthDay ... cholesterol and one is an anti-inflammatory -- may be ... presented at the American Association for Cancer Research annual ... and the statin Lipitor, when used together or alone, ...
... Kimmel Cancer Center at Thomas Jefferson University in ... blood pressure medications might help prevent the spread ... laboratory that one type of pressure-lowering drug called ... growth and causes cell death. , In earlier ...
... Real-Time In Vivo Data via Quantitative ... ... Inc., a leader,in fluorescence in vivo imaging, today announced the commercial ... is based on VisEn,s,proprietary Fluorescence Molecular Tomography (FMT(TM)) technology,platform, and combined ...
... 14 HealthFusion, a,national clearinghouse for ... center operation customer satisfaction excellence under ... Center Program(SM). This distinction,acknowledges a strong ... to provide "An Outstanding Customer Service ...
... As the first of the,nation,s 78 million baby boomers ... health care work force that is too small and ... new report from the Institute of,Medicine. The report calls ... providers -- not just specialists -- in the basics ...
... Denise Kehoe has joined,medication therapy management (MTM) company ... new role, she will manage and oversee the,expansion ... the country., Kehoe brings more than 15 ... PharmMD. She recently served as national strategic,executive of ...
Cached Medicine News:Health News:Celebrex Plus Lipitor Could Fight Prostate Cancer 2Health News:Celebrex Plus Lipitor Could Fight Prostate Cancer 3Health News:Blood pressure drugs halt pancreatic cancer cell growth, Jefferson researchers find 2Health News:VisEn Medical Launches FMT(TM) 2500 - Next-Generation Fluorescence Imaging System 2Health News:J.D. Power and Associates Reports: HealthFusion Recognized for Providing an Outstanding Customer Service Experience 2Health News:J.D. Power and Associates Reports: HealthFusion Recognized for Providing an Outstanding Customer Service Experience 3Health News:Health Care Work Force Too Small, Unprepared for Aging Baby Boomers; Higher Pay, More Training, and Changes in Care Delivery Needed to Avert Crisis 2Health News:PharmMD Announces Denise Kehoe as Vice President of Business Development 2
(Date:7/27/2015)... and PARIS , July 28, 2015 ... Sanofi have entered into a new global collaboration to ... the emerging field of immuno-oncology. As part of the ... cell death protein 1 (PD-1) inhibitor currently in Phase ... 2016 with new therapeutic candidates based on ongoing, innovative ...
(Date:7/27/2015)... United Kingdom , July 27, 2015 /PRNewswire/ ... a leading specialty biopharmaceutical company, announced today that ... which it will sell its global contrast media ... NYSE Euronext) in a transaction valued at approximately ... divest its CMDS business is consistent with the ...
(Date:7/27/2015)... and PITTSBURGH , July 27, ... that it will hold its extraordinary general meeting of shareholders ... (NYSE: PRGO ; TASE) at the Okura Hotel Amsterdam ... Time (CET). Among other agenda items at ... on the approval, under article 2:107a of the Dutch Civil ...
Breaking Medicine Technology:Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 2Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 3Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 4Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 5Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 6Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 7Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 8Mallinckrodt Enters Agreement To Sell Its Contrast Media And Delivery Systems Imaging Business To Guerbet For $270 Million 2Mallinckrodt Enters Agreement To Sell Its Contrast Media And Delivery Systems Imaging Business To Guerbet For $270 Million 3Mallinckrodt Enters Agreement To Sell Its Contrast Media And Delivery Systems Imaging Business To Guerbet For $270 Million 4Mallinckrodt Enters Agreement To Sell Its Contrast Media And Delivery Systems Imaging Business To Guerbet For $270 Million 5Mallinckrodt Enters Agreement To Sell Its Contrast Media And Delivery Systems Imaging Business To Guerbet For $270 Million 6Mallinckrodt Enters Agreement To Sell Its Contrast Media And Delivery Systems Imaging Business To Guerbet For $270 Million 7Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 2Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 3Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 4Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 5Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 6Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 7Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 8Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 9Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 10
... 2011 Double Eagle Holdings, Ltd. (OTCQB: ... www.fusescience.com ), announced today that it has entered into ... Inc. (PDT Inc.), a California-based pharmaceutical consulting firm. Double ... Inc., the developer of new, patent-pending technologies poised to ...
... the worldwide leader in 3D Molecular Breast Imaging (MBI), ... the Naviscan Board of Directors. Dr. Cheng ... in the medical device industry.  He served as the ... Inc.  After acquisition by Ethicon, Inc., a Johnson & ...
Cached Medicine Technology:Double Eagle Holdings Enters Into Supply Agreement with Platform Delivery Technologies Inc. 2Double Eagle Holdings Enters Into Supply Agreement with Platform Delivery Technologies Inc. 3Naviscan Further Strengthens its Board of Directors With the Addition of Dr. Andre Cheng 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: